Alcon IOLs, Bausch & Lomb Refractive Surgery Generate Q1 Growth
Alcon expects its AcrySof Natural intraocular lenses to continue to drive surgical sales, having accounted for 27% of U.S. IOL sales at the end of the first quarter
Alcon expects its AcrySof Natural intraocular lenses to continue to drive surgical sales, having accounted for 27% of U.S. IOL sales at the end of the first quarter